Aurora Biosciences Reports Higher Q1 Revenues, Dips into Red | GenomeWeb

NEW YORK, May 3 – Two days after its acquisition by Vertex Pharmaceuticals, Aurora Biosciences reported higher earnings for the first quarter of 2001, but drifted into the red during its last full quarter as an independent company. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.